Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a open-label multicenter study of CM-101 for COVID-19 pneumonia
MOH_2020-07-21_009158Phase 2Not yet recruiting
- Sponsor
- פרופ' יאיר לוי
- Start
- Jul 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of nebokitug in coronavirus disease 2019 (COVID-19) and pneumonia, sponsored by פרופ' יאיר לוי. Planned start Jul 2020; status: not yet recruiting.
02
Drugs
nebokitug
03
Conditions
coronavirus disease 2019 (COVID-19)pneumonia
Beyond the preview
Go deeper on MOH_2020-07-21_009158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2020-07-21_009158.